These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways. Liu G; Zhang F; Jiang Y; Hu Y; Gong Z; Liu S; Chen X; Jiang Q; Hao J Mult Scler; 2017 Feb; 23(2):205-212. PubMed ID: 27207450 [TBL] [Abstract][Full Text] [Related]
5. Profile of differential promoter activity by nucleotide substitution at GWAS signals for multiple sclerosis. Ryu J; Woo J; Shin J; Ryoo H; Kim Y; Lee C Medicine (Baltimore); 2014 Dec; 93(28):e281. PubMed ID: 25526461 [TBL] [Abstract][Full Text] [Related]
6. Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment. Mahurkar S; Moldovan M; Suppiah V; O'Doherty C PLoS One; 2013; 8(2):e57655. PubMed ID: 23469041 [TBL] [Abstract][Full Text] [Related]
7. Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. International Multiple Sclerosis Genetics Consortium Am J Hum Genet; 2013 Jun; 92(6):854-65. PubMed ID: 23731539 [TBL] [Abstract][Full Text] [Related]
8. Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C. Martin P; McGovern A; Massey J; Schoenfelder S; Duffus K; Yarwood A; Barton A; Worthington J; Fraser P; Eyre S; Orozco G PLoS One; 2016; 11(11):e0166923. PubMed ID: 27861577 [TBL] [Abstract][Full Text] [Related]
9. Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis. Elangovan RI; Disanto G; Berlanga-Taylor AJ; Ramagopalan SV; Handunnetthi L J Hum Genet; 2014 Apr; 59(4):211-5. PubMed ID: 24522295 [TBL] [Abstract][Full Text] [Related]
10. [Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)]. Favorova OO; Bashinskaia VV; Kulakova OG; Favorov AV; Boĭko AN Mol Biol (Mosk); 2014; 48(4):573-86. PubMed ID: 25842843 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) Nat Genet; 2009 Jul; 41(7):824-8. PubMed ID: 19525955 [TBL] [Abstract][Full Text] [Related]
15. Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes. Ma Q; Shams H; Didonna A; Baranzini SE; Cree BAC; Hauser SL; Henry RG; Oksenberg JR Commun Biol; 2023 Mar; 6(1):342. PubMed ID: 36997638 [TBL] [Abstract][Full Text] [Related]
16. Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment. Liu A; Manuel AM; Dai Y; Zhao Z BMC Genomics; 2022 May; 23(Suppl 4):362. PubMed ID: 35545758 [TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations. Alcina A; Abad-Grau Mdel M; Fedetz M; Izquierdo G; Lucas M; Fernández O; Ndagire D; Catalá-Rabasa A; Ruiz A; Gayán J; Delgado C; Arnal C; Matesanz F PLoS One; 2012; 7(1):e29819. PubMed ID: 22253788 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. International Multiple Sclerosis Genetics Consortium (IMSGC) Hum Mol Genet; 2010 Mar; 19(5):953-62. PubMed ID: 20007504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]